Signal from the log
Navion Neurosciences
10,8 M$ · Seed · United States · Biotech
Société préclinique installée à Charlottesville, en Virginie, qui conçoit des médicaments ciblant les canaux sodiques. Ses deux programmes de tête visent les épilepsies génétiques et la douleur neuropathique chronique. Il s'agit d'une première clôture, l'annonce ne dit pas la taille visée du tour complet.
Verified
Announced on , logged by the watch of 9 September 2026.
- Operation
- Funding round
- Announced amount
- 10,8 M$
- Stage
- Seed
- Country
- United States
- Sector
- Biotech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Angelini Lumira Biosciences Fund , with 3B Future Health Fund , UVA LVG Seed Fund , Virginia Innovation Partnership Corporation , VTC Innovation Fund
Provenance
Source businesswire,edgar
Logged on 9 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.